Inhibiting elements of the proteasome recovery pathway sensitizes glioblastoma to proteasome inhibitors

被引：0
|
作者：
Anand, Alisha
Shaikh, Muhammad Vaseem
Chokshi, Chirayu
Brakel, Benjamin
Maich, William
Grewal, Shan
Venugopal, Chitra
Singh, Sheila
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5846
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5846
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Proteasome inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1998, 3 (06) : 295 - 296
  • [12] Proteasome Inhibitors
    Cvek, Boris
    PROTEASOMAL SYSTEM IN AGING AND DISEASE, 2012, 109 : 161 - 226
  • [13] Natural Product Inhibitors of the Ubiquitin-Proteasome Pathway
    Schneekloth, John S., Jr.
    Crews, Craig M.
    CURRENT DRUG TARGETS, 2011, 12 (11) : 1581 - 1594
  • [14] Modulation of the ubiquitin-proteasome pathway (UPP) sensitizes colonic carcinoma to apoptosis: the potential of proteasome inhibition in the treatment of colon carcinoma
    McCawley, N.
    Conlon, S.
    Dicker, P.
    Concannon, C. G.
    Prehn, J. H. M.
    Kay, E. W.
    Deasy, J.
    McNamara, D.
    BRITISH JOURNAL OF SURGERY, 2010, 97 : 34 - 35
  • [15] Proteasome inhibition for the treatment of glioblastoma
    Roth, Patrick
    Mason, Warren P.
    Richardson, Paul G.
    Weller, Michael
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (10) : 1133 - 1141
  • [16] The ubiquitin proteasome system and efficacy of proteasome inhibitors in diseases
    Chitra, Selvarajan
    Nalini, Ganesan
    Rajasekhar, Gopalakrishnan
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2012, 15 (03) : 249 - 260
  • [17] MECHANISMS THAT DETERMINE THE EFFICACY OF TWO PROTEASOME INHIBITORS, BORTEZOMIB AND MARIZOMIB, IN GLIOBLASTOMA
    Manton, Christa
    Chandra, Joya
    NEURO-ONCOLOGY, 2011, 13 : 108 - 108
  • [18] Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors
    Mahdi Pakjoo
    Seyed Esmaeil Ahmadi
    Mohammad Zahedi
    Niloofar Jaafari
    Reyhane Khademi
    Ali Amini
    Majid Safa
    Cell Communication and Signaling, 22
  • [19] Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors
    Pakjoo, Mahdi
    Ahmadi, Seyed Esmaeil
    Zahedi, Mohammad
    Jaafari, Niloofar
    Khademi, Reyhane
    Amini, Ali
    Safa, Majid
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [20] Proteasome inhibitors as therapeutics
    Mitsiades, CS
    Mitsiades, N
    Hideshima, T
    Richardson, PG
    Anderson, KC
    ESSAYS IN BIOCHEMISTRY, VOL 41: THE UBIQUITIN-PROTEASOME SYSTEM, 2005, 41 : 205 - 218
12345